A new daily weight loss pill could be available soon – and a recent trial has shown that people taking the drug can shed kilos in weeks. Its release will offer people with obesity a new and convenient alternative to jabs. Pharmaceutical company Eli Lilly said it expects substantial demand when the new pill is launched.

In a Phase 3 trial, drugmaker Eli Lilly and Company said it's oral GLP-1 pill showed similar results to injectable weight loss options after a 72-week period.

Eli Lilly is one step closer to bringing an oral weight loss medicine to the booming obesity drug market. A clinical trial saw people lose 12% of body weight.